Product Overview
[Drug Name]
Generic Name: Glutamine And Guaiazulene Sulfonate Sodium Granules
Trade Name: Guao Glutamine And Guaiazulene Sulfonate Sodium Granules 660mg: 2mg*15 bags
Pinyin Code: GuAo GuAnZuoAnShengHuangSuanNaKeLi 660mg: 2mg*15 bags
[Main Ingredients]
This product is a compound preparation containing 2mg of sodium glutamate and 660mg of glutamine per bag.
[Properties]
This product is a slightly light blue granule.
[Indications/Main Functions]
It is used to improve the symptoms and signs of gastritis, gastric ulcers, and duodenal ulcers.
[Specifications]
660mg: 2mg x 15 sachets (Guao)
[Dosage and Administration]
Usually, adults take one sachet three times daily, 30 minutes before meals, or pour the sachet into 30ml of warm or cold water, stir thoroughly until completely dissolved, and then take orally. Do not drink large amounts of water after taking the medication. The dosage may be adjusted appropriately based on symptoms.
[Adverse Reactions]
Adverse reactions may be mild. Nausea, constipation, and diarrhea may occur occasionally.
[Contraindications]
Contraindicated in patients with allergies to this product or its ingredients.
[Drug Interactions]
Drug interactions may occur if used with other medications. Please consult your physician or pharmacist for details.
[Precautions]
Unknown.
[Pediatric Use]
The dosage for children should be reduced or directed by a physician.
[Elderly Use]
Use with caution in the elderly.
[Overdose]
Unknown.
[Pharmacology and Toxicology]
This product is a combination preparation of sodium mosulfate and L-glutamine. Sodium oxalate can directly act on inflamed mucosa, exerting anti-inflammatory effects. Animal studies have shown that it can effectively inhibit aspirin-induced ulcers. L-glutamine promotes the biochemical synthesis of hexamethylenetetramine and glucosamine, components of the gastrointestinal mucosal epithelium, and has protective and repairing effects on gastrointestinal mucosal damage. In experiments with pyloric ligation in rats, glutamine inhibited ulcers caused by aspirin and indomethacin. This compound preparation has promoted the healing of various experimental ulcers in rats, suggesting therapeutic benefits for low-acid (acid-free) ulcers. Furthermore, this compound preparation can inhibit the production of pepsinogen in the rat gastric mucosa.
